FDA Inspection
Clario IncClario Inc – FDA Inspection, May 12, 2022
Record Details
This FDA Inspection record concerns Clario Inc, with an inspection on May 12, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Clario Inc
- Inspection Date
- May 12, 2022
- Product Type
- Drugs
View Company Profile
ID · 09bed324-77a0-4102-8526-8c5978366a4f
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1171672
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Clario Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 4, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 10, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 5, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 26, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 8, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Clario Inc
- FDA Inspection 1163670 - 2022-03-04
- FDA Inspection 1161294 - 2022-01-10
- FDA Inspection 1136432 - 2021-02-05
- FDA Inspection 1106258 - 2019-09-26
- FDA Inspection 1014836 - 2017-06-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.